Endotronix的动态

Thought experiment number 2??: In a clinical vacuum, devoid of GPO contracts, Big Blue Bias/dogma and resistance to “different” interfaces, would a VDD device be the standard of care for primary prevention ICD patients (with a specific focus on, but not limited to, AHRE burden monitoring and OAC administration)? Great paper from Drs. Carniero and Knight in JCE looks at the idea of “Does Asymptomatic Atrial Fibrillation Exist?”, as reminded by Mohamed Elshazly, MD MBEE during Western AF last weekend. Many of the ideas presented here tie into the MATRIX study (Europace) as well… Anticoagulation Forum #epeeps #afib #atrialfibrillation BIOTRONIK

Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR: https://lnkd.in/gKf-PAma

Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR: https://lnkd.in/gKf-PAma

It is time to embark on the creation of a Cardiogenic Shock Team Collaborative with a goal to promote sharing of care protocols, education of stakeholders, and discovery of how process and performance may influence patient outcomes, quality, resource consumption, and costs of care. The over-arching by goal of a cardiogenic shock team is to improve outcomes and identify best practices.

Real World Evidence at the service of HCPs to make the best decision for their patients

Our recent study from CMDR!! CMD assessment is safe and requires only slightly additional contrast use (10?mL) and slightly longer fluoroscopy time (2?min) without clinical implications. These findings emphasize the favorable safety and feasibility of invasive CMD assessment. https://lnkd.in/exEpbhFF

US HCPs: Firstline use of the Indigo System for ALI patients resulted in low 30-day amputation rates, and high rates of technical success. Learn more at https:// https://lnkd.in/gxdjX9jc. Rx only. Risk info: peninc.info/risk Clinical results may vary

What is the impact of point-of-care (POC) devices for accurate clinical decision-making in patient blood management??? ? Dr. Timothy Maul, CCP, FPP, PHD, a perfusionist and senior research scientist at Nemours Children’s Health, delves into how ECMO provides essential heart and lung support for patients with inadequate blood perfusion. He also explores the challenges of patient blood management during #ECMO and the critical role of accurate POC devices in clinical decision-making. ? ? Read the full article here: https://lnkd.in/e9e5hhD8 #PBMAW2024?#SABMPBMAwarenessWeek?#CriticalCare?#PBM

Reprieve Cardiovascular Nabs $42M to Expand Intelligent Fluid Management for Heart Failure - HIT Consultant #ReprieveCardiovascular Funding Round Reprieve Cardiovascular, a healthcare IT company, has secured $42 million in funding to expand its intelligent fluid management system for heart failure patients. #HealthTechFunding #IntelligentFluidManagement Technology The company's technology uses advanced algorithms to monitor and manage fluid levels in heart failure patients, helping to prevent complications and improve outcomes. #HeartFailureTech #Benefits of Intelligent Fluid Management By providing real-time data and personalized insights, Reprieve Cardiovascular's system can help healthcare providers make more informed treatment decisions and improve patient care. #HealthcareInnovation #Expansion Plans With the new funding, Reprieve Cardiovascular plans to expand its reach and impact by partnering with more healthcare facilities ai.mediformatica.com #hospital #management #miion #heart #heartfailure #patients #clinical #seriesa #patientoutcomes #deerfieldmanagement #financing #hospitaladmiions #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/3IeCVVG)

This case study illustrates the diagnostic value and clinical utility of ECG in patients with QT interval prolongation and torsades de pointes. #ECG #LQT #Tdp #GE HealthCare #DCARInsights